Document is current
Any future updates will be listed below
-
Authors
Nielsen, Kári Rubek
Modin, Frederikke Agerbo
Midjord, Jóngerð
Vang, Amanda
Berbisá, Marjun á Fríðriksmørk
Johannesen, Herborg Líggjasardóttir
Dahlerup, Jens Frederik
Andersen, Vibeke
Neumann, Anders
Kjeldsen, Jens
Pedersen, Natalia
Langholz, Ebbe
Munkholm, Pia
Hammer, Turid
Burisch, Johan
-
Funding
Funding for this research was provided by:
Faroese Research Council
Torben & Alice Frimodts Foundation
Aage & Johanne Louis-Hansens Foundation
Faroese Foundation
Betri Foundation
EU Horizon Europe program grant miGut-Health: personalised blueprint of intestinal health (101095470)
Copenhagen University
- License Information
-
More Information
Article History
Received: 2 October 2024
Accepted: 25 October 2024
First Online: 14 November 2024
Declarations
:
: JB reports grants and personal fees from AbbVie, Janssen-Cilag, MSD, Takeda, Tillots Pharma, and Bristol Myers Squibb. JB also reports personal fees from Celgene, Pfizer, Samsung Bioepis, Pharmacosmos, Ferring, and Galapagos and grants from Novo Nordisk, unrelated to the submitted work. EL reports speaker’s fees from Ferring Pharmaceuticals, Takeda, Janssen-Cilag, Tillotts, and MSD. EL also reports having served as an advisory board member for Ferring Pharmaceuticals and Takeda. VA reports personal fees from MSD (Merck) unrelated to the submitted work.
